Medical
Technology
Animas designs,
manufactures and markets products and services for patients with
insulin-requiring diabetes. Its mission is to improve the lifestyle
of patients, reduce the long-term morbidity of the disease and
lower costs to patients and the health care system. Animas was
acquired by Johnson & Johnson in
February 2006.
Aspect
Medical Systems (NASDAQ: ASPM) is recognized as a pioneer
and global market leader in brain monitoring, having led the
way to develop proprietary technologies and ultimately improve
the quality and cost effectiveness of patient care.
Ciphergen (NASDAQ:
CIPH) is a leading provider of enabling tools and collaborative
services in the emerging field of protein-based biology research,
known as proteomics. Ciphergen develops and manufactures a ProteinChip®
System that helps researchers understand the role of proteins
in the biology of disease, such as monitoring disease progression
and the therapeutic effects of drugs.
Confluent
Surgical markets synthetic, polymer-based, sprayable
adhesion barriers and surgical sealants. These materials
have potential applications across minimally invasive surgery
in adhesion prevention, as sealants and hemostats, and in
interventional procedures. Confluent was sold to the U.S.
Surgical division of Tyco International in August 2006.
EXACT
Sciences Corporation (NASDAQ: EXAS) is an applied
genomics company whose mission is to play a leading role
in the eradication of common cancers by applying advances
in the field of genomics to facilitate early detection of
disease.
Guava
Technologies, Inc. is a biotechnology company that
develops, manufactures and markets unique, high-impact cellular
analysis systems for the life science research marketplace.
Guava's patented technology has revolutionized the way scientists
perform cell-based analysis.
Interlace
Medical designs and develops devices for the
Interventional Gynecologist to perform office-based procedures
to treat diseases and conditions traditionally requiring
surgery in the operating room.
Pathway
Medical Technologies, Inc.designs, develops and manufactures
innovative medical devices intended for the treatment of
arterial disease with a major focus on peripheral artery
disease.
Praecis Pharmaceuticals (NASDAQ: PRCS) is a biotechnology
company focused on the discovery and development of pharmaceutical
products using its proprietary LEAPTM (Ligand Evolution to Active
Pharmaceuticals) technology. The company is currently targeting
the treatment of prostate cancer, endometriosis and Alzheimer's
disease.
Satiety develops minimally invasive devices to treat
obesity and certain other gastrointestinal conditions.
Soteira, Inc. is developing a system for treatment of
vertebral compression fractures in patients with osteoporosis,
cancer or traumatic injuries. Soteira’s design provides a superior
biomechanical structure and better control of cement flow than
competing solutions.
Spinal
Conceptsprovides the surgical community with the
most technologically advanced implants used in the treatment
of spinal disorders, diseases and injuries. The company is
a leader in technology with more than 40 U.S. patent awards,
22 foreign patents and numerous additional patents pending
on product innovations. Spinal Concepts was sold to Abbott
Laboratories in 2003.
Spinal
KineticsDevelops innovative and practical motion
preservation systems for treating degenerative diseases of
the spine.
Tandem
Diabetes CareDeveloper of a novel insulin pump technology
for the treatment of diabetes.
Transcend
Medical Developer of novel devices for the treatment
of glaucoma.
Valeritas develops
proprietary drug delivery systems for Type 2 diabetes and metabolic
diseases.
|
